Allogene Therapeutics (ALLO) EBIT Margin (2021 - 2026)
Allogene Therapeutics (ALLO) reported EBIT Margin of -1011.21% for Q2 2026.
Powered by 
Analysis
Allogene Therapeutics (ALLO) EBIT Margin (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Allogene Therapeutics' EBIT Margin came in at -3886.14%; for FY2024, it came in at -1241813.64%, down 896827.32 percentage points from FY2023.
- EBIT Margin has declined for three consecutive years, with a three-year change of -1241655.70 percentage points (FY2021 to FY2024).
- By year, EBIT Margin came in at -344986.32% in FY2023 (-129899.14 pp), -215087.18% in FY2022 (-214929.24 pp) and -157.94% in FY2021.
- The Q2 2026 figure ranks as the highest quarterly EBIT Margin since Q4 2021.
- The high point for year-over-year EBIT Margin in five years was Q2 2022 (a gain of 41717.05 percentage points); the low point was Q4 2022 (a drop of 370752.26 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 28.37% |
| 10 | Allogene Therapeutics | 401.29 Mn | -700.60 Mn | - | -1,011.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,011.21% |
| Mar 31, 2024 | -315,927.27% |
| Dec 31, 2023 | -405,280.95% |
| Sep 30, 2023 | -286,345.45% |
| Jun 30, 2023 | -366,090.91% |
| Mar 31, 2023 | -330,306.67% |
| Dec 31, 2022 | -370,750.00% |
| Sep 30, 2022 | -305,596.30% |
| Jun 30, 2022 | -119,712.50% |
| Mar 31, 2022 | -205,164.10% |
| Dec 31, 2021 | 2.26% |
| Sep 30, 2021 | -158,510.20% |
| Jun 30, 2021 | -161,429.55% |
| Mar 31, 2021 | -86.58% |
API Access
Allogene Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();